Apollomics Stock (NASDAQ: APLM) stock price, news, charts, stock research, profile.
Open | $0.12 |
Close | $0.14 |
Volume / Avg. | 1.83M / 3.93M |
Day Range | $0.12 - $0.14 |
52 Wk Range | 0.12 - 5.02 |
Market Cap | $15.14M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 0.41% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Apollomics (NASDAQ:APLM) through any online brokerage.
Other companies in Apollomics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Can Fite Biofarma (AMEX:CANF) and Sensei Biotherapeutics (NASDAQ:SNSE).
Apollomics has a consensus price target of $8.50.
The stock price for Apollomics (NASDAQ: APLM) is $0.138 last updated August 23, 2024 at 7:54 PM EDT.
There are no upcoming dividends for Apollomics.
Apollomics’s H1 earnings are confirmed for Wednesday, August 14, 2024.
There is no upcoming split for Apollomics.
Apollomics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.